Interrad Medical Inc.
This article was originally published in Start Up
Executive Summary
Venous access catheters are held in place on the skin's surface with sutures, tape, or adhesive-backed catheter stabilization devices. None of these attachment methods are ideal: catheters frequently dislodge, requiring reinsertion from trained staff. Bacteria that accumulate on the skin under a sutured-down catheter hub or in tacky adhesives are a primary culprit in catheter-related bacterial infections. Interrad Medical aims to address these shortcomings with a subcutaneous catheter securement system, which anchors catheters in the fatty layer just beneath the surface of the skin.
You may also be interested in...
Start-Up Previews (11/2007)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Antibody Start-Ups," features profiles of 4-Antibody, Anaptys Biosciences and f-star. Plus these Start-Ups Across Health Care: Actuality Medical, INBONE Technologies, Interrad Medical and Tethys BioScience.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”